High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia (HDL)

This study has been completed.
Sponsor:
Collaborator:
Sunovion
Information provided by (Responsible Party):
Herbert Meltzer, Northwestern University
ClinicalTrials.gov Identifier:
NCT01569659
First received: March 29, 2012
Last updated: December 8, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)